Androstenedione
- Product NameAndrostenedione
- CAS63-05-8
- CBNumberCB8365581
- MFC19H26O2
- MW286.41
- EINECS200-554-5
- MDL NumberMFCD00003615
- MOL File63-05-8.mol
- MSDS FileSDS
Chemical Properties
| Melting point | 170-171 °C(lit.) |
| alpha | D30 +199° (in chloroform) |
| Boiling point | 368.77°C (rough estimate) |
| Density | 1.0655 (rough estimate) |
| refractive index | 1.4709 (estimate) |
| Flash point | 2℃ |
| storage temp. | Controlled Substance, -20°C Freezer |
| solubility | Chloroform (Slightly), Ethanol (Slightly, Sonicated), Methanol (Sparingly) |
| form | Solid |
| color | Dimorphous: Needles from acetone, or crystalsfrom hexane |
| Water Solubility | 57.28mg/L(25 ºC) |
| Merck | 13,643 |
| InChI | 1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 |
| InChIKey | AEMFNILZOJDQLW-QAGGRKNESA-N |
| SMILES | [H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)C(=O)CC[C@@]24[H] |
| Toxicology and Carcinogenesis | Toxicology and Carcinogenesis Studies of Androstenedione (CASRN 63-05-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies) |
| CAS DataBase Reference | 63-05-8(CAS DataBase Reference) |
| FDA UNII | 409J2J96VR |
Safety
| Symbol(GHS) |
![]()
|
|||||||||
| Signal word | Danger | |||||||||
| Hazard statements | H225-H302+H312+H332-H319 | |||||||||
| Precautionary statements | P210-P261-P280-P305+P351+P338-P370+P378-P403+P235 | |||||||||
| Hazard Codes | Xn,T,F | |||||||||
| Risk Statements | 40-64-52-22-61-60-36-20/21/22-11 | |||||||||
| Safety Statements | 22-24/25-36-45-36/37-53-26-16 | |||||||||
| RIDADR | UN 1648 3 / PGII | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | BV8150000 | |||||||||
| HS Code | 29372900 | |||||||||
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects | |||||||||
| Hazard Classifications | Acute Tox. 4 Oral Carc. 2 Lact. Repr. 1A | |||||||||
| Hazardous Substances Data | 63-05-8(Hazardous Substances Data) | |||||||||
| NFPA 704: |
|

